Sigrid van Bladel

Kanisa Pharmaceuticals, Inc. develops pharmaceuticals and provides medical services. The company develops drugs for diagnosis and treatment of cancer. It was founded by David A. Socks and is located in San Diego, CA.

Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA.

NXThera, Inc. provides technology platform to treat endourological conditions. It develops medical devices to treat patients suffering from urologic conditions, such as benign prostatic hyperplasia (BPH), prostate cancer, and kidney cancer. The company was founded by John H. Shadduck and Michael Hoey in 2008 and is headquartered in Maple Grove, MN.

Aberdare Management Co. LLC (Aberdare Ventures) is a venture capital firm founded in 1999 by Paul H. Klingenstein. The firm is headquartered in San Francisco, California.

Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO.

VertiFlex, Inc. operates as a medical device company. It offers minimally invasive solutions for the treatment of lumbar spinal stenosis (LSS), which is the cause of spinal surgery in the elderly. The firm specializes in minimally invasive, motion preservation, spine and medical device. The company was founded by Moti Altarac in 2005 and is headquartered in San Clemente, CA.

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA.